In vivo increase in β-adrenergic lipolytic response in subcutaneous adipose tissue of obese subjects submitted to a hypocaloric diet

Journal of Clinical Endocrinology and Metabolism

Volumn 82, Issue 1, 1997, Pages 63-69

  Barbe, P ^a   Stich, V ^b   Galitzky, J ^a   Kunesova, M ^b   Hainer, V ^b   Lafontan, M ^a   Berlan, M ^a  

^a INSERM   (France)

^b CHARLES UNIVERSITY   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

4 (3 TERT BUTYLAMINO 2 HYDROXYPROPOXY) 2 BENZIMIDAZOLONE; BETA ADRENERGIC RECEPTOR; DOBUTAMINE; ISOPRENALINE; TERBUTALINE;

ADULT; ARTICLE; BLOOD FLOW VELOCITY; CALORIC RESTRICTION; CLINICAL ARTICLE; DRUG EFFECT; DRUG RECEPTOR BINDING; FEMALE; GLYCEROL BLOOD LEVEL; HUMAN; LIPOLYSIS; MALE; OBESITY; PRIORITY JOURNAL; RECEPTOR UPREGULATION; SKIN BLOOD FLOW; SUBCUTANEOUS FAT; VASODILATATION;

EID: 0031024684     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.82.1.63     Document Type: Article

References (52)

1. Lafontan M, Berlan M. 1993 Fat cell adrenergic receptors and the control of white and brown fat cell function. J Lipid Res. 34:1057-1091.
2. Coppack SW, Jensen MD, Miles JM. 1994 In vivo regulation of lipolysis in humans. J Lipid Res. 35:177-193.
3. Wolfe RR, Peter EJ, Klein S, Holland OB, Rosenblatt J, Gary H. 1987 Effect of short-term fasting on lipolytic responsiveness in normal and obese human subjects. Am J Physiol. 252:E189-E196.
4. Jensen MD, Haymond MW, Rizza RA, Cryer PE, Miles JM. 1989 Influence of body fat distribution on free fatty acid metabolism in obesity. J Clin Invest. 83:1168-1173.
5. Reynisdottir S, Ellerfeldt K, Wahrenberg H, Lithell H, Amer P. 1994 Multiple lipolysis defects in the insulin resistance (metabolic) syndrome. J Clin Invest. 93:2590-2599.
6. Östman J, Arner P, Kimura H, Wahrenberg H, Engfeldt P. 1984 Influence of fasting on lipolytic response to adrenergic agonists and on adrenergic receptors in subcutaneous adipocytes. Eur J Clin Invest. 14:383-391.
7. Kather H, Wieland E, Fisher B, Wirth A, Schlierf G. 1985 Adrenergic regulation of lipolysis in abdominal adipocytes of obese subjects during caloric restriction: reversal of catecholamine action caused by relief of endogenous inhibition. Eur J Clin Invest. 15:30-37.
8. Crampes F, Marceron M, Beauville M, et al. 1989 Platelet alpha2-adrenoceptors and adrenergic adipose tissue responsiveness after moderate hypocaloric diet in obese subjects. Int J Obes. 13:99-110.
9. Arner P, Engfeldt P, Nowak J. 1981 In vivo observations on the lipolytic effect of noradrenaline during therapeutic fasting. J Clin Endocrinol Metab. 53:1207-1212.
10. Jensen MD, Haymond MW, Gerich JE, Cryer PE, Miles JM. 1987 Lipolysis during fasting: decreased suppression by insulin and increased stimulation by epinephrine. J Clin Invest. 87:207-213.
11. Lönnqvist F, Krief S, Strosberg AD, Nyberg B, Emorine LJ, Arner P. 1993 Evidence for a functional beta3-adrenoceptor in man. Br J Pharmacol. 110:929-936.
12. Langin D, Portillo M, Saulnier-Blache J-S, Lafontan M. 1991 Coexistence of three beta-adrenergic receptor subtypes in white fat cells of various mammalian species. Eur J Pharmacol. 199:291-301.
13. 3-adrenergic effect on lipolysis in human subcutaneous adipose tissue. J Clin Endocrinol Metab. 77:352-355.
14. Van Liefde I, Ermen AV, Vauquelin G. 1994 No functional atypical beta-adrenergic receptors in human omental adipocytes. Life Sci. 54:209-214.
15. Lönnqvist F, Thöme A, Nilsell K, Hoffstedt J, Arner P. 1995 A pathogenic role of visceral fat β3-adrenoceptors in obesity. J Clin Invest. 95:1109-1116.
16. Enocksson S, Shimizu M, Lönnqvist F, Nordenström J, Arner P. 1995 Demonstration of in vivo functional β3-adrenoceptor in man. J Clin Invest. 95:2239-2245.
17. Barbe P, Millet L, Galitzky J, Lafontan M, Berlan M. 1996 In situ assessment of the role of β1-, β2-, β3-adrenoceptors in the control of lipolysis and nutritive blood flow in human subcutaneous adipose tissue. Br J Pharmacol. 117:907-913.
18. 3H]CGP 12177, generally classified as an antagonist, is a thermogenic agonist in brown adipose tissue. Biochem J. 261:401-405.
19. Jacobson I, Sandberg M, Hamberger A. 1985 Mass transfer in brain dialysis devices - a new method for the estimation of extracellular amino acid concentration. J Neurosci Methods. 15:263-268.
20. Maggs DG, Jacob R, Rife F, et al. 1995 Interstitial fluid concentrations of glycerol, glucose, and amino acids in human quadriceps muscle and adipose tissue. J Clin Invest. 96:370-377.
21. Hickner RC, Rosdahl H, Borg I, Ungerstedt U, Jorfeldt L, Henriksson J. 1991 Ethanol may be used with the microdialysis technique to monitor blood flow changes in skeletal muscle: dialysate glucose concentration is blood flow-dependent. Acta Physiol Scand. 143:355-356.
22. Galitzky J, Lafontan M, Nordenström J, Arner P. 1993 Role of vascular alpha2-adrenoceptors in regulating lipid mobilization from human adipose tissue. J Clin Invest. 91:1997-2003.
23. Bradley DC, Kaslow HR. 1989 Radiometric assays for glycerol, glucose and glycogen. Anal Biochem. 180:11-16.
24. Bernst E, Gutmann I. 1974 Determination of ethanol with alcohol deshydrogenase and NAD. In: Bergmeyer HU, ed. Methods of enzymatic analysis. Verlag Weinheim; 1499-1505.
25. Jansson P-A, Larsson A, Smith U, Lönnroth P. 1992 Glycerol production in subcutaneous adipose tissue of lean and obese humans. J Clin Invest. 89:1610-1617.
26. Jansson P-A, Smith U, Lönnroth P. 1990 Interstitial glycerol concentration measured by microdialysis in two subcutaneous regions in humans. Am J Physiol. 258:E918-E922.
27. Arner P, Kriegholm E, Engfeldt P, Bounder J. 1990 Adrenergic regulation of lipolysis in situ at rest and during exercise. J Clin Invest. 85:893-898.
28. Frayn KN, Shadid S, Hamlani R, et al. 1994 Regulation of fatty acid movement in human adipose tissue in the postabsorptive-to-postprandial transition. Am J Physiol. 266:E308-E317.
29. Berlan M, Dang-Tran L, Lafontan M, Denard Y. 1981 Influence of hypocaloric diet on alpha-adrenergic responsiveness of obese human subcutaneous adipocytes. Int J Obes. 5:145-153.
30. Zapf J, Waldvogel M, Froesch ER. 1977 Increased sensitivity of rat adipose tissue to the lipolytic action of epinephrine during fasting and its reversal during refeeding. FEBS Lett. 75:135-138.
31. Dax E, Partilla JS, Gregerman RJ. 1981 Increased sensitivity to epinephrine-stimulated lipolysis during starvation: tighter coupling of the adenylate cyclase complex. Biochem Biophys Res Commun. 101:1186-1192.
32. Kempen KPG, Saris WHM, Senden JMG, Menheere PP, Blaak EE, Baak MAV. 1994 Effects of energy restriction on acute adrenoceptor and metabolic response to exercise in obese subjects. Am J Physiol. 267:E694-E701.
33. Engfeldt P, Hellmer J, Wahrenberg H, Arner P. 1988 Effects of insulin on adrenoceptor binding and the rate of catecholamine-induced lipolysis in isolated human fat cells. J Biol Chem. 263:15553-15560.
34. Arner P, Bounder J. 1991 Microdialysis of adipose tissue. J Intern Med. 230:381-386.
35. Enocksson S, Nordenström J, Bolinder J, Arner P. 1995 Influence of local blood flow on glycerol levels in human adipose tissue. Int J Obes. 19:350-354.
36. Arner P, Bolinder J, Eliasson A, Lundin A, Ungerstedt U. 1988 Microdialysis of adipose tissue and blood for in vivo lipolysis studies. Am J Physiol. 255:E737-E742.
37. Emorine LJ, Marullo S, Briend-Sutren MM, et al. 1989 Molecular characterization of the human beta3-adrenergic receptor. Science. 245:1118-1121.
38. Thomas RF, Liggett SB. 1993 Lack of beta3-adrenergic receptor mRNA expression in adipose and other metabolic tissues in the adult human. Mol Pharmacol. 43:343-348.
39. Krief S, Lönnqvist F, Raimbault S, et al. 1993 Tissue distribution of beta3-adrenergic receptor mRNA in man. J Clin Invest. 91:344-349.
40. Revelli JP, Muzzin P, Paoloni A, Moinat M, Giacobino J-P. 1993 Expression of the beta3-adrenergic receptor in human white adipose tissue. J Mol Endocrinol. 10:193-197.
41. Manara L, Croci T, Landi M. 1995 β3-Adrenoceptors and intestinal motility. Fund Clin Pharmacol. 9:332-342.
42. Shen Y-T, Zhang H, Vatner SF. 1994 Peripheral vascular effects of beta3-adrenergic receptor stimulation in conscious dogs. J Pharmacol Exp Ther. 268:466-473.
43. Berlan M, Galitzky J, Bousquet-Melou A, Lafontan M, Montastruc J-L. 1994 Beta3-adrenoceptor-mediated increase in cutaneous blood flow in the dog. J Pharmacol Exp Ther. 268:1444-1451.
44. Berlin Y, Berlan M, Crespo-Laumonnier B, et al. 1990 Alterations in β-adrenergic sensitivity and platelet α2-adrenoceptors in obese women: effect of exercise and caloric restriction. Clin Sci. 78:81-87.
45. Danforth E. 1983 The role of thyroid hormones and insulin in the regulation of energy metabolism. Am J Clin Nutr. 38:1006-1017.
46. Di Biase G, Mattioli PL, Contaldo F, Mancini M. 1981 A very-low-calorie formula diet (Cambridge diet) for the treatment of diabetic/obese patients. Int J Obes. 5:319-324.
47. Atkinson RL, Kaiser DL. 1985 Effects of calorie restriction and weight loss on glucose and insulin levels in obese humans. J Am Coll Nutr. 4:411-419.
48. O'Dea K, Esler M, Leonard P, Stockigt JR, Nestel P. 1982 Noradrenaline turnover during under- and overeating in normal weight subjects. Metabolism. 31:896-899.
49. Schwartz RS, Jaeger LF, Veeith RC, Lakshmimarayan S. 1990 The effect of diet or exercise on plasma norepinephrine kinetics in moderately obese young men. Int J Obes. 14:1-11.
50. Cignarelli M, Pergola GD, Garruti G, et al. 1990 Changes in overall plasma norepinephrine turnover and lymphomonocyte beta-adrenoceptor number during combine caloric and sodium restriction in normotensive obese subjects. Int J Obes. 14:429-437.
51. Leibel RF, Berry EM, Hirsh J. 1991 Metabolic and hemodynamic responses to endogenous and exogenous catecholamines in formerly obese subjects. Am J Physiol. 260:R785-R791.
52. Reynisdottir S, Langin D, Carlström K, Holm C, Rössner S, Amer P. 1995 Effects of weight reduction on the regulation of lipolysis in adipocytes of women with upper-body obesity. Clin Sci. 89:421-429.